Table 1.

The association between AP-2γ expression levels and outcomes of patients with breast cancer.

AP-2γ level	Type of BC	Outcomes	Reference
↑	ERα-positive and endocrine therapy-treated patients	Disease-free survival↓ and overall survival after 10 yr↓	[28,29]
↑	ERα-positive with fulvestrant-treated patients	Response to fulvestrant treatment↓	[30]
↑(with Wwox↓)	Tamoxifen-resistant patients	Response to tamoxifen↓	[31,32]
↑(with CD44↓)	Patients with basal-derived breast cancer	Reaching pathologic complete response upon neoadjuvant chemotherapy↑	[33]

AP-2γ = activator protein-2 gamma, BC = breast cancer, ER = estrogen receptor, Wwox = WW domain containing oxidoreductase.